Bernitsas Law has provided legal counsel to CVC and Hellenic Healthcare Group (HHG) regarding the sale of a 60% stake in HHG to PureHealth Holding PJSC. This transaction values HHG at €2.2 billion and is pending regulatory approvals. Following the completion of the deal, CVC and HHG’s CEO will maintain a strategic partnership by retaining a 40% stake in the company.

CVC is recognized as a leading global player in private equity and credit, operating through a network of 30 local offices worldwide. HHG stands out as the largest private healthcare provider in Greece and Cyprus, highlighting its significant role in the region's healthcare landscape.

The legal complexities of the transaction involved navigating Greek law, particularly concerning HHG's domestic operations and existing contractual obligations, including bank financing and third-party consents. The Bernitsas Law team, which comprised various legal experts, played a crucial role in addressing these challenges.

The team included Partners Maria Nefeli Bernitsa, Nikos Papachristopoulos, Athanasia Tsene, and Tania Patsalia, along with Associate Marinos Shiapanis and Counsels Maria Kloni and Christina Zakopoulou. Additionally, Senior Associates Fotini Karra, Maria Sofia Sfika, and Ria Venaki, as well as Associates Maira Drymousi, Vasiliki Fasfali, Yolanda Kalogirou, Marialena Mavrikaki, and Niki Nisotaki contributed to the effort.

This transaction marks a significant development in the healthcare sector, reflecting the ongoing consolidation and investment trends within the industry. The collaboration between CVC, HHG, and PureHealth is expected to enhance HHG's capabilities and expand its reach in the healthcare market.